Tsao, P. A., Urban-Wojcik, E., Seewald, M., Khan, A., Bryant, A., Palmbos, P. L., Smith, D. C., Tsung, I., Vaishampayan, U. N., Yentz, S. E., Alumkal, J. J., Reichert, Z. R., Caram, M. V. (2026). Impact of abiraterone versus enzalutamide on depression and anxiety in hormone-sensitive prostate cancer (HSPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.147